Lyra Therapeutics (LYRA) Asset Utilization Ratio (2021 - 2025)
Quarterly Asset Utilization Ratio fell 52.83% to 0.01 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2025, down 52.83% year-over-year, with the annual reading at 0.01 for FY2025, 47.09% down from the prior year.
Lyra Therapeutics' Asset Utilization Ratio history spans 5 years, with the latest figure at 0.01 for Q4 2025.
- Asset Utilization Ratio came in at 0.01 for Q4 2025, down from 0.01 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.02 in Q4 2024 to a low of 0.0 in Q4 2021.
- The 5-year median for Asset Utilization Ratio is 0.01 (2023), against an average of 0.01.
- Year-over-year, Asset Utilization Ratio soared 155.62% in 2022 and then crashed 52.83% in 2025.
- Lyra Therapeutics' Asset Utilization Ratio stood at 0.0 in 2021, then skyrocketed by 155.62% to 0.01 in 2022, then dropped by 0.35% to 0.01 in 2023, then skyrocketed by 78.58% to 0.02 in 2024, then plummeted by 52.83% to 0.01 in 2025.
- Per Business Quant, the three most recent readings for LYRA's Asset Utilization Ratio are 0.01 (Q4 2025), 0.01 (Q3 2025), and 0.01 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.60 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 0.47 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 0.37 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.29 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 0.85 |
| 10 | Lyra Therapeutics | - | - | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.01 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | 0.01 |
| Jun 30, 2023 | 0.01 |
| Mar 31, 2023 | 0.01 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.00 |